Bio Decontamination Market Share

North American Market Forecast

The North American bio decontamination market is projected to hold the largest market share by the end of 2037, attributed the growing awareness among the public about the potential hazards posed by microbial contamination, which caused an increase in the demand for bio decontamination solutions in the region. Additionally, the increasing adoption of advanced decontamination technologies, such as UV-C, ozone, and hydrogen peroxide, has further propelled the market growth in the region. Moreover, the large number of pharmaceutical companies in region such as Johnson & Johnson, Eli Lilly and Co, Pfizer Inc, and Merck & Co Inc., which require the use of bio decontamination techniques to safely produce drugs and treatments is expected to fuel regional market growth. Furthermore, recent advancements in biotechnology have enabled the development of more advanced and advanced bio decontamination technologies, which are also driving investments and spending in the field. For instance, almost half of global pharmaceutical production (47%) and 23% of the industry are produced in the US. Based on the Congressional Budget Office's estimate, the pharmaceutical industry spent USD 83 billion on research and development in 2019.

APAC Market Statistics

The Asia Pacific bio decontamination market is projected to hold the second largest share during the forecast period, attributed to the rising number of healthcare-associated infections, increasing prevalence of chronic and communicable diseases, the growing demand for cleanroom sterilization, and the growing demand for bio decontamination services. Moreover, the growing geriatric population in the Asia Pacific region has contributed to an increase in the number of elderly people requiring specialized medical care. It is estimated that the Chinese population is aging at one of the fastest rates in the world. China's population over 60 is expected to grow to 28% by 2040. Over the next ten years, the number of older Indians (60 and over) is expected to more than double from 139 million to 195 million, an increase of 40%. Infectious diseases are more likely to infect elderly people since they visit hospitals frequently and have weakened immune systems. As a result, there is increased demand for biodecontamination solutions to mitigate the risk of healthcare-associated infections.

Europe Market Forecast

Further, the bio decontamination market in the Europe is projected to hold a majority of the share by the end of 2037, attributed to the growing demand for bio-decontamination in the pharmaceutical industry owing to its safety and efficacy, as well as the increasing prevalence of nosocomial infections. The use of antibiotics has caused bacteria to become resistant, leading to an increase in the number of nosocomial infections. To combat this, bio decontamination is necessary to reduce the risk of spreading disease and infection. Additionally, growing awareness regarding the need for bio-decontamination along with the increased use of antibiotics, which has created an urgent need for bio-decontamination solutions is expected to fuel the growth of the market in the region. As a result, governments in the region have become more stringent with their regulations regarding bio-decontamination protocols in pharmaceutical facilities, resulting in an increase in the use of these products and services.